510(k) K811777

HELENA PLASMINOGEN QUIPLATE PROCEDURE by Helena Laboratories — Product Code DDX

K811777 is an FDA 510(k) premarket notification submitted by Helena Laboratories for the device "HELENA PLASMINOGEN QUIPLATE PROCEDURE". The FDA issued a decision of Substantially Equivalent on July 2, 1981. The device falls under product code DDX (Plasminogen, Antigen, Antiserum, Control), a Class I device regulated under 21 CFR 866.5715. Helena Laboratories has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 2, 1981
Date Received
June 23, 1981
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Plasminogen, Antigen, Antiserum, Control
Device Class
Class I
Regulation Number
866.5715
Review Panel
HE
Submission Type